Literature DB >> 17001684

Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer.

Michelle Craig Barton1, Said Akli, Khandan Keyomarsi.   

Abstract

In this review, we focus on pathways intersecting through p53 and cyclin E, highlighting how oncogenic effects of cyclin E deregulation, especially overexpression of shortened or low molecular weight (LMW) forms of cyclin E protein, are amplified by loss of regulatory control through p53 to promote tumor development. Expression of cyclin E protein promotes progression into S-phase, an activity opposed by p53-regulated activation of checkpoint controls or apoptosis. Loss of p53 function is an escape hatch by which tumor cells, initiated by a number of means including cyclin E deregulation, can avoid cell cycle arrest or cell death and progress through further stages of unchecked deregulation and growth. To determine how this escape hatch is opened and, ultimately, how to close it, we must understand the networks of normal signaling and processing in a cell and where they intersect. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001684     DOI: 10.1002/jcp.20818

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Anaplastic thyroid cancer, tumorigenesis and therapy.

Authors:  J P O'Neill; D Power; C Condron; D Bouchier-Hayes; M Walsh
Journal:  Ir J Med Sci       Date:  2009-08-07       Impact factor: 1.568

2.  Effect of curcumin on aged Drosophila melanogaster: a pathway prediction analysis.

Authors:  Zhi-guo Zhang; Xu-yan Niu; Ai-ping Lu; Gary Guishan Xiao
Journal:  Chin J Integr Med       Date:  2013-10-23       Impact factor: 1.978

3.  Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin.

Authors:  A Bera; X-M Leighton; H Pollard; M Srivastava
Journal:  Trends Cancer Res       Date:  2018

4.  An integrative model links multiple inputs and signaling pathways to the onset of DNA synthesis in hepatocytes.

Authors:  Jérémy Huard; Stephanie Mueller; Ernst D Gilles; Ursula Klingmüller; Steffen Klamt
Journal:  FEBS J       Date:  2012-04-10       Impact factor: 5.542

5.  Protein expression patterns of cell cycle regulators in operable breast cancer.

Authors:  Flora Zagouri; Vassiliki Kotoula; George Kouvatseas; Maria Sotiropoulou; Triantafyllia Koletsa; Theofani Gavressea; Christos Valavanis; Helen Trihia; Mattheos Bobos; Georgios Lazaridis; Angelos Koutras; George Pentheroudakis; Pantelis Skarlos; Dimitrios Bafaloukos; Niki Arnogiannaki; Sofia Chrisafi; Christos Christodoulou; Pavlos Papakostas; Gerasimos Aravantinos; Paris Kosmidis; Charisios Karanikiotis; George Zografos; Christos Papadimitriou; George Fountzilas
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

6.  SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.

Authors:  Viviana E Hermosilla; Ginessa Salgado; Elizabeth Riffo; David Escobar; Matías I Hepp; Carlos Farkas; Mario Galindo; Violeta Morín; María A García-Robles; Ariel F Castro; Roxana Pincheira
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

7.  Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.

Authors:  Qianqian Yuan; Lewei Zheng; Yiqin Liao; Gaosong Wu
Journal:  World J Surg Oncol       Date:  2021-03-23       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.